3-rx.comCustomer Support
3-rx.com
   
HomeAbout UsFAQContactHelp
News Center
Health Centers
Medical Encyclopedia
Drugs & Medications
Diseases & Conditions
Medical Symptoms
Med. Tests & Exams
Surgery & Procedures
Injuries & Wounds
Diet & Nutrition
Special Topics



\"$alt_text\"');"); } else { echo"\"$alt_text\""; } ?>


Join our Mailing List





Syndicate

You are here : 3-RX.com > Home > Drug News -

NSAIDs won’t protect ultra-marathoners’ muscles

Drug NewsDec 26, 07

Taking non-steroidal anti-inflammatory drugs (NSAIDs) like ibuprofen during endurance events does not help prevent muscle damage or next-day muscle soreness, a study in ultra-marathoners indicates.

In fact, using NSAIDs during competition could actually be bad for muscles, Dr. Steven McAnulty of Appalachian State University in Boone, North Carolina and colleagues found.

Based on their findings, they urge caution in using NSAIDs during ultra-distance exercise events.

Long, marathon-type runs are known to create a state of “oxidative stress” that damages cells in the body over time. But it’s not clear whether oxidative stress during endurance workouts causes muscle damage.

To investigate, and also determine how taking NSAIDs might influence the relationship, McAnulty’s team looked at markers of muscle damage and oxidative stress in 60 men and women before and after they competed in the Western States Endurance Run, during which they ran160 kilometers (99-mile) in 77 hours, on average.

Seventy-two percent of the runners used NSAIDs during the race, most frequently ibuprofen.

According to McAnulty and colleagues, there were no differences in blood levels of proteins indicating muscle damage between the NSAID users and athletes who didn’t use these medications. Levels of most oxidative stress indicators also were the same in both groups after the race. And there was no relationship between oxidative stress and a competitor’s degree of post-race muscle soreness.

However, levels of protein carbonyls (PCs)—key indicators of oxidative stress—were “dramatically increased” after the race in NSAID users only.

And athletes who had taken NSAIDs actually reported more muscle soreness the day after the race than those who didn’t take these medications.

SOURCE: International Journal of Sports Medicine, November 2007.



Print Version
Tell-a-Friend
comments powered by Disqus

RELATED ARTICLES:
  New biomarkers may influence drug design and alternative treatments of cancer, study shows
  UGA ecologist finds another cause of antibiotic resistance
  New drug for neuroblastoma shows promise in phase I study
  Baclofen shows promise in patients with alcohol-induced liver disease
  Findings point to an ‘off switch’ for drug resistance in cancer
  Stopping statins may benefit terminally ill patients
  Cholesterol drug users may use pills as a license to overeat
  Pfizer lung cancer drug beats chemo for previously untreated patients
  Mass. General study identifies path to safer drugs for heart disease, cancer
  Gates Foundation awards Notre Dame $23 million for malaria, dengue studies
  Cancer drug protects against diabetes
  Malaria drug target raises hopes for new treatments

 












Home | About Us | FAQ | Contact | Advertising Policy | Privacy Policy | Bookmark Site